What is MDCX's dilution risk score?

MDCX currently has a DilutionScore of 62/100, indicating high dilution risk. DilutionWatch monitors MDCX SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

What SEC filings does DilutionWatch track for MDCX?

DilutionWatch tracks 25 SEC filing types for MDCX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect MDCX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For MDCX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for MDCX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for MDCX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

MDCX Stock Dilution Tracker: Score 62/100 (HIGH)

📊 Score Breakdown

📋 Offering Ability

65

💰 Cash Runway

85

📊 Float Risk

5

⚠️ Warrant Exposure

15

🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️

Warning

High probability of dilution event

67%

💰 Capital Raise 73%

• Low cash runway: 5 months remaining

• Active shelf registration ($8M, 37% of market cap)

🔄 Reverse Split 70%

• 50-day avg $0.36 below $1 exchange minimum

• Only 5 months cash — financial pressure

📉 Score Deterioration 50%

• Score rose 44 points recently (worsening)

• Score in HIGH risk zone (62/100)

🔔 Track MDCX — Get forecast alerts →

💹 Market Data

Market Cap$21.47M

Shares Outstanding56.66M

Float50.14M

Cash$6.37M

Debt$2.53M

Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 3.93M shares

#1 Armistice Capital, LLC 1.81M shares

#2 Interchange Capital Partners, LLC 1.66M shares

#3 Private Advisor Group, LLC 175.5K shares

+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest2.19M

Days to Cover1.0

% of Float4.4%

FINRA data as of May 15, 2026

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025

xbrl XBRL CONVERTIBLE Dec 31, 2025

424B3 ATM May 14, 2026

424B3 ATM Apr 30, 2026

424B3 ATM Apr 27, 2026

Full SEC filing analysis available with free account →

📰 Recent News

Medicus Pharma secures up to $22M in non-dilutive financing facility Proactive · May 28

Medicus Pharma Ltd. (MDCXW) Reports FDA Progress and Expands 2026 Clinical Outlo Insider Monkey · May 19

Medicus Pharma lobbies Congress on SkinJect regulatory pathway for rare Gorlin s Proactive · Apr 27

🔬 More Research for MDCX

📊 MDCX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MDCX Signal Convergence & Dark Pool Activity — StonkWhisper 📄 MDCX Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

MDCX — Medicus Pharma Ltd. Dilution Risk Tracker